Abstract
Venous thromboembolism (VTE) is an important cause of morbidity and mortality following major orthopaedic surgery. However, the incidence of VTE and the role of additional risk factors have not yet been well explored in Italian clinical practice. The objective of the study is to estimate the incidence of VTE in the 3 months following elective hip and knee replacement (HR, KR) in a large cohort of patients, and the association between some selected risk factors and the occurrence of VTE. A large cohort study based on the record linkage between automated archives of the National Health System was analysed. In particular, all the residents in the Lombardy Region (Italy) who underwent HR and KR between 2005 and 2008 were followed for 3 months after surgery. The odds ratio (OR) of VTE associated with selected known risk factors was estimated by multivariate logistic regression. Amongst the 69,770 patients included in the study, 2,393 experienced at least one VTE event during the follow-up; the overall risk of VTE after HR or KR was 3.4%. The adjusted odds of experiencing a VTE event was higher in male patients (OR 1.11; 95% confidence interval 1.01–1.21), aged 60 years or older (1.30; 1.00–1.68), undergoing KR (1.47; 1.35–1.61), with previous deep vein thrombosis (1.96; 1.20–3.19), pulmonary embolism (3.25; 1.84–5.75) or cancer (1.21; 1.00–1.46). In conclusion, the incidence of VTE after elective HR and KR in the Italian clinical practice is high. Our results suggest the need of optimising the management of thromboprophylaxis to further reduce postoperative VTE.
Similar content being viewed by others
References
Shorr AF, Kwong LM, Sarnes M, Happe L, Farrelly E, Mody-Patel N (2007) Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis. Thromb Res 121:17–24
Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, Nilsson P, Nylander G (1996) Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 335:696–700
Comp PC, Spiro TE, Friedman RJ, Whitsett TL, Johnson GJ, Gardiner GA, Gardiner GA Jr, Landon GC, Jove M (2001) Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am 83-A:336–345
Nakase J, Toribatake Y, Mouri Y, Seki H, Kitaoka K, Tomita K (2009) Heparin versus danaproid for prevention of venous thromboembolism after hip surgery. J Orthop Surg (Hong Kong) 17:6–9
Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:381S–453S
Alikhan R, Peters F, Wilmott R, Cohen AT (2004) Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol 57:1254–1257
Eikelboom JW, Quinlan DJ, Douketis JD (2001) Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 358:9–15
Ganz DA, Glynn RJ, Mogun H, Knight EL, Bohn RL, Avorn J (2000) Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med 15:776–781
Geerts W (2009) Prevention of venous thromboembolism: a key patient safety priority. J Thromb Haemost 7(Suppl 1):1–8
Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE (2001) Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 135:858–869
Imberti D, Prisco D (2005) Venous thromboembolism prophylaxis in medical patients: future perspectives. Thromb Res 116:365–375
Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL (2002) Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology 96:1140–1146
Leclerc JR, Gent M, Hirsh J, Geerts WH, Ginsberg JS (1998) The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1, 984 patients. Canadian Collaborative Group. Chest 114:115S–118S
Verhaeghe R (2005) Extended prophylaxis of venous thromboembolism in major orthopaedic surgery. Acta Orthop Belg 71:255–259
Corrao G, Cesana G, Merlino L (2008) Pharmacoepidemiological research and linking of electronic databases available in the Italian region of Lombardy. Biomed Stat Clin Epidemiol 2:117–125
ISTAT: Censimento Generale della Popolazione e delle Abitazioni. Available at:http://www.dawinciistatit/MD
Claes N, Buntinx F, Vijgen J, Arnout J, Vermylen J, Fieuws S, Van LH (2005) The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial. Eur Heart J 26:2159–2165
Edmonds MJ, Crichton TJ, Runciman WB, Pradhan M (2004) Evidence-based risk factors for postoperative deep vein thrombosis. ANZ J Surg 74:1082–1097
Gangireddy C, Rectenwald JR, Upchurch GR, Wakefield TW, Khuri S, Henderson WG, Henke PK (2007) Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 45:335–341
Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM (2009) A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 360:1851–1861
Isma N, Svensson PJ, Gottsater A, Lindblad B (2009) Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmo Thrombophilia Study (MATS). Thromb Res 124:663–666
Lacut K, van der Maaten J, Le GG, Cornily G, Mottier D, Oger E (2008) Antiplatelet drugs and risk of venous thromboembolism: results from the EDITH case–control study. Haematologica 93:1117–1118
Jewell NP (2004) Statistics for epidemiology. Chapman and Hall, Boca Raton
Schabenberger O (2008) Introducing the GLIMMIX procedure for generalized linear mixed models. SAS Institute Inc., Cary (2008)
Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36
The Thrombosis Interest Group of Canada: Clinical Guide—The prevention of deep vein thrombosis in medical patients, 2008. Available at http://www.tigc.org/pdf/PrevDVTMedPat.pdf
Ageno W, Squizzato A, Garcia D, Imberti D (2006) Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost 32:651–658
Severinsen MT, Johnsen SP, Tjonneland A, Overvad K, Dethlefsen C, Kristensen SR (2010) Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Eur J Intern Med 21:268–272
Davidson HC, Mazzu D, Gage BF, Jeffrey RB (1996) Screening for deep venous thrombosis in asymptomatic postoperative orthopedic patients using color Doppler sonography: analysis of prevalence and risk factors. AJR Am J Roentgenol 166:659–662
Samama MM (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160:3415–3420
Imberti D, Dallasta C (2008) Clinical benefits of rivaroxaban for thromboprophylaxis after major orthopaedic surgery. Adv Orthop 1:8–16
Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293:715–722
Corrao G, Zambon A, Conti V, Nicotra F, La VC, Fornari C, Cesana G, Contiero P, Tagliabue G, Nappi RE, Merlino L (2008) Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation. Ann Oncol 19:150–155
Randelli F, Biggi F, Della RG, Grossi P, Imberti D, Landolfi R, Palareti G, Prisco D Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery. J Orthop Traumatol. doi:10.1007/s10195-010-0125-8
Fattore G, Colangelo I, Martelli E, Cheli A, Del Sasso L (2004) Methods and costs of venous thromboembolism prophylaxis in orthopedic surgery in Italy. Pharmacoecon Italian Res Articles 6:69–80
Acknowledgments
This study was supported by an unrestricted educational grant by Bayer.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Imberti, D., Bianchi, C., Zambon, A. et al. Venous thromboembolism after major orthopaedic surgery: a population-based cohort study. Intern Emerg Med 7, 243–249 (2012). https://doi.org/10.1007/s11739-011-0567-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-011-0567-x